PMV, a Belgian investment company, focuses on providing venture capital, growth capital, and private debt to ambitious companies and projects, particularly in Flanders, with an emphasis on both social impact and financial return. Their strategy involves co-financing with the market, acting as active and patient investors without predetermined exit dates, and investing across sectors such as Enterprise Applications, Life Sciences, biotech, cleantech, IT, and infrastructure.
Their most common stage is series-a (71% of deals). Average disclosed round size is $32.2M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$1.7B
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| OOnTracx | Seed | $1.2M | Sep 2025 |
| AAugustine Therapeutics | Series A | $77.7M | Mar 2025 |
 Swave Photonics | Series A | $27M | Jan 2025 |
| Swave Photonics | Series A | $28.3M | Jan 2025 |
| DDualyx | Series A | $44M | May 2023 |
| KKebony | Series B | $34M | Oct 2021 |
| NNobi | Series A | $13M | — |
Top Co-Investors
imec.xpand2 shared
IAG Capital Partners2 shared
Luminate2 shared
Lightrock1 shared
MVP Ventures1 shared
Fountain Healthcare1 shared
Forbion1 shared
Andera Partners1 shared
BGV1 shared
HTGF1 shared
Imec.istart1 shared
QBIC1 shared
Novo Holdings1 shared
Jeito Capital1 shared
Asabys1 shared
Eli Lilly and Company1 shared
AdBio1 shared
Last updated: 6 March 2026